Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DBC AGM Information 2026

May 25, 2026

52428_rns_2026-05-25_7df243b0-eef4-43c3-a1db-6e71a872792a.pdf

AGM Information

Open in viewer

Opens in your device viewer

Stock Code: 4764

img-0.jpeg

Double Bond Chemical Ind. Co., Ltd.

2026 Annual Shareholders' Meeting Meeting Agenda

Date: 10:00 am Thursday, June 25, 2026

Location: Meeting Room, 4F, No. 959, Zhongzheng Road, Zhonghe District, New Taipei City, Taiwan (R.O.C.)


Table of Contents

Page

I. Meeting Procedures 1
II. Meeting Agenda 2
I. Report Items 3
II. Ratification Items 4
III. Election Item 4
IV. Other Proposals 5
V. Extraordinary Motions 6
III. Appendix
I. 2025 Business Report 7
II. Audit Committee’s Review Report 11
III. Independent Auditors’ Report and 2025 Consolidated Financial Statements 12
IV. Independent Auditors’ Report and 2025 Parent Company Only Financial Statements 22
V. 2025 Earnings Distribution Table 32
VI. The list of candidates for directors and independent directors 33
IV. Annex
I. Articles of Incorporation 36
II. Rules and Procedures for Shareholders Meetings 42
III. The Procedures for Election of Directors 56
IV. Shareholding of All Directors 59
V. Other Matters 60


1

Double Bond Chemical Ind. Co., Ltd.
2026 Annual General Shareholders' Meeting Procedures

I. Call Meeting to Order
II. Chairman's Speech
III. Report Items
IV. Ratification Items
V. Election Item
VI. Other Proposals
VII. Extraordinary Motions
VIII. Meeting Adjourned


Double Bond Chemical Ind. Co., Ltd.
2026 Annual General Shareholders' Meeting Agenda

Time: 10:00am Thursday, June 25, 2026

Venue: Meeting Room, 4F, No. 959, Zhongzheng Road, Zhonghe District, New Taipei City, Taiwan (R.O.C.)

Method of Convening the Meeting: Physical shareholders' meeting

I. Call Meeting to Order

II. Chairman's Speech

III. Report Items:
(I) The 2025 Business Report.
(II) The Audit Committee's 2025 Review Report.
(III) Report on the Employees' Compensation and Directors' Remuneration of 2025.
(IV) Report on the 2025 Earnings Distribution of cash dividends.

IV. Ratification Items:
(I) The 2025 Business Report and Financial Statements.
(II) The 2025 Earnings Distribution Proposal.

V. Election Item:
(I) Election for The Board of Directors.

VI. Other Proposals:
(I) Proposal for Release the Prohibition on Directors for participation in Competitive Business.

VII. Extraordinary Motions

VIII. Meeting Adjourned

2


Report Items

Report No. 1:

Agenda: The 2025 Business Report.

Explanatory Note: Please refer to Appendix 1 for the 2025 Business Report.

Report No. 2:

Agenda: The Audit Committee's 2025 Review Report.

Explanatory Note: Please refer to Appendix 2 for the Audit Committee’s Review Report.

Report No. 3:

Agenda: Report on the Employees’ Compensation and Directors’ Remuneration of 2025.

Explanatory Note:

I. According to Article 20 of the Company's Articles of Incorporation, if the Company is profitable in the year, it shall allocate no less than 1% for the employees’ compensation and no more than 5% for the directors’ remuneration. However, if the Company has accumulated losses, it should retain the amount of compensation in advance before paying the employees’ compensation and the directors’ remuneration according to the proportion set forth in the preceding paragraph.

II. The Board of Directors resolved on March 13, 2026, to distribute the 2025 cash compensation to employees of NT$4,000,000 and remuneration to directors of NT$6,000,000, which completely align with the estimated amounts recognized in the 2025 financial statements. Notably, an amount of NT$2,209,816, representing 55.25% of the total employee compensation, has appropriated specifically for non-executive employees. Both distributions will be paid fully in cash.

Report No. 4:

Agenda: Report on the 2025 Earnings Distribution of cash dividends.

Explanatory Note:

I. Please refer to Appendix 5 for the 2025 Earnings Distribution Table.

II. The cash dividends were calculated in the unit of NTD and rounded down to the first digit of NTD. Amounts less than 1NTD were added up before recognizing the Company’s other income.

III. The chairperson was authorized by the Board of Directors to decide the ex-dividend date, date of issuance, and other relevant issues. If proposed distribution of earnings is affected by a change in the Company's outstanding common shares, the chairperson is authorized by the Board of Directors to make adjustment to such distribution at his/her discretion.

IV. The ex-dividend record date for the cash dividend has been scheduled for May 1, 2026, and the payment has been scheduled to be distributed on May 29, 2026.


Ratification Items

Ratification No. 1

Agenda: The 2025 Business Report and Financial Statements. (Proposed by the Board of Directors).

Explanatory Note:

I. For the year ended December 31, 2025, the Company’s business report, parent company only financial statements and consolidated financial statements were approved by the Board of Directors and the Company’s parent company only financial statements and consolidated financial statements were verified by Accountant CHUANG, YEH-WEI and Accountant LEE, TUNG-FENG of Deloitte & Touche. Together with the business report, the aforementioned documents were sent to the Audit Committee for review and approval. A review report was issued thereafter.

II. For the foregoing business report, please refer to Appendix 1. For the audit committee’s review report, please refer to Appendix 2. For the financial statements, please refer to Appendix 3 & 4.

III. Submitted for ratification.

Resolutions:

Ratification No. 2

Agenda: The 2025 Earnings Distribution Proposal. (Proposed by the Board of Directors).

Explanatory Note:

I. The 2025 Earnings Distribution Table was approved by the Board of Directors and reviewed by the Audit Committee. Please refer to Appendix 5.

II. Submitted for ratification.

Resolutions:

Election Item

Election No. 1

Agenda: Election for The Board of Directors. (Proposed by the Board of Directors).

Explanatory Note:

I. The term of office of the current director is expired on June 27, 2026. According to Article 14 of the Articles of Incorporation, the Company has five to nine directors, of whom the number of independent directors shall not be less than two and not less than one-fifth of the number of directors. The number of directors to be elected for the current session shall be seven (including three independent directors).

II. The newly elected directors will take office immediately after their election at the annual shareholders’ meeting for a term of three years, from June 25, 2026, to June 24, 2029.

III. The list of candidates for directors and independent directors has been examined and approved by the Board of Directors. For their academic qualifications, experience and other relevant


information, please refer to Appendix 6.

IV. Submitted for election.

Resolutions:

Other Proposals

Proposal No. 1

Agenda: Proposal for Release the Prohibition on Directors for participation in Competitive Business. (Proposed by the Board of Directors).

Explanatory Note:

I. According to Paragraph 1 of Article 209 of the Company Act, a director who conducts any investment or business activity for himself or on behalf of others that falls within the scope of the Company's business shall explain the essential contents of such activity to the Shareholders' Meeting and obtain its approval.

II. Since the election of directors (including independent directors) of the Company adopts a candidate nomination system, and to facilitate shareholders in exercising their voting rights via electronic means, the details regarding the lifting of non-compete restrictions on directors (including independent directors) are disclosed in advance as shown in the table below. Upon the election of the new directors (including independent directors) at the Shareholders' Meeting, supplementary explanations regarding the specific scope and contents of such restrictions will be provided on-site prior to the discussion of this proposal.

Title Name Company names and positions of concurrent employment
Director LEE, KUN-CHANG • General Manager of HG CO., LTD.
• Director of SIN HUN CHEMICAL CO., LTD.
• Supervisor of FDC, Lees Co., Ltd.
• Supervisor of RUYU CO., LTD.
• Chairperson of BEST ROUND CO., LTD.
• Chairperson of CPCO CO., LTD.
Director Representative of Jatdix Investments International Limited LIU, CHIEN-LIANG • Director of JATDIX INVESTMENTS INTERNATIONAL LIMITED
• Supervisor of T-BAL CO., LTD.
• Corporate representative director of Innonyx International Co., Ltd.
• Supervisor of JATDITA Investments Co., Ltd.
• Director of ACCE Biotech Company Limited
• Director of Circular Power Biotech Biology Co., Ltd.
• Supervisor of Green Carbon Sustainability Technology Co., Ltd.

Title Name Company names and positions of concurrent employment
Director LIN, LIANG • Chairperson of JATDIX INVESTMENTS INTERNATIONAL LIMITED
• Corporate representative chairperson of Innonyx International Co., Ltd.
• Chairperson of JATDIA International Business Co., Ltd.
• Chairperson of JATDITA Investments Co., Ltd.
• Corporate representative supervisor of QTS CORPORATION
• Corporate representative director of VisionaryBioMed Limited
• Supervisor of ACCE Biotech Company Limited
• Corporate representative director of T-BAL CO., LTD.
Director TSAY, MAW-DER • Director of DBC Switzerland AG
• Director of Double Bond Chemical (Thailand) Co., Ltd.
• Director of DBC KOREA CO., LTD.
• Corporate director’s representative of SIN HUN CHEMICAL CO., LTD.
Independent Director CHANG, SHU-MEI • Professor of Molecular Science and Engineering, National Taipei University of Technology
• Supervisor of Taiwan Textile Research Institute
• Supervisor of The Society of Taiwan Women in Science and Technology
Independent Director WANG, REN-CHAIN • Distinguished Researcher of Industrial Technology Research Institute

III. Submitted for discussion.

Resolutions:

Extraordinary Motions

Meeting Adjourned


[Appendix 1]

Double Bond Chemical Ind. Co., Ltd.

2025 Business Report

(I) Business plan implementation outcome

The consolidated operating income of the Company in 2025 was NT$2,849,976 thousand, representing a year-over-year increase of approximately 5%. The consolidated net profit after tax attributable to the owner of the Company was NT$104,540 thousand, representing a year-over-year increase of approximately 380%.

(II) Budget Execution Status: The Company has not disclosed any financial forecasts; therefore, this section is not applicable.

(III) Revenue, Expense, and Profitability Analysis

  1. Financial revenues and expenditures

In Thousands of New Taiwan Dollars

Items 2025 2024
Operating income 2,849,976 2,702,450
Operating profit margin 564,859 368,478
Net operating gain (loss) 165,401 ( 26,898 )
Non-operating income and expenditure ( 14,805 ) ( 5,215 )
Net profit (loss) before tax 150,596 ( 32,113 )
Net profit (loss) this term 107,366 ( 34,703 )
Net profit (loss) attributable to owners of the company 104,540 ( 37,290 )
Net profit (loss) attributable to non-controlling interest 2,826 2,587
  1. Profitability Analysis:

% ; Earnings (Loss) Per Share in New Taiwan Dollars

Items 2025 2024
Return on asset (%) 2.86 ( 0.10 )
Return on equity (%) 4.62 ( 1.71 )
Proportion of net operating income (loss) to the paid-in capital (%) 19.34 ( 3.14 )
Proportion of net profit (loss) before tax to the paid-in capital (%) 17.60 ( 3.75 )
Net profit (loss) margin (%) 3.67 ( 1.38 )
Earnings (loss) per share 1.22 ( 0.44 )

(IV) Research and Development

Core R&D Products of the Group

2025 R&D Results Future R&D Directions
Plastics Additives (1) Low-alkalinity light stabilizer for agricultural films
(2) Polyolefin high-efficiency light stabilizer and masterbatch
(3) Composite phenol-free and anti-fogging additive for polyurethane bra cup foam (1) Anti-scorching additive for bio-based polyurethane foam
(2) High-performance antistatic additive for high-transparency polycarbonate
(3) Eco-friendly UV protection solution for thermoplastic polyurethane — free from restricted substances
UV Curable Materials (1) Highly flexible/fast rebound oligomer
(2) Development of PC/Low RI oligomer
(3) Excimer oligomer/full formula development (1) 3D printing oligomer /full formula development
(2) Flame retardant oligomer
(3) Continue to develop excimer oligomer/full formula development
Digital Textile Materials (1) High-concentration UV-curable pigment paste
(2) High-chromaticity water-based coating pigment paste
(3) Water-based UV absorber for textiles
(4) Digital inkjet printing outsourcing for various materials (1) Water-based pigment ink textile OEM and development
(2) Customized UV-curable ink OEM and development for various materials
(3) Development of water-based UV absorbers for textiles
(4) Development of water-based infrared additives for textiles
Electronic Materials (1) 5G / 6G materials (1) Continue to develop 5G / 6G materials
(2) COC electronic materials
(3) Flame retardants electronic materials
(4) Other electronic materials

(V) Operating Guidelines and Sales Strategies

The Company offers a diversified range of products, and market trends vary across different segments. Our operational objective is to achieve growth in both revenue and profitability. Based on historical sales records, ongoing customer negotiations, market supply and demand conditions, and new product development plans, the overall sales volume in 2026 is expected to grow steadily.


The Company’s future business strategies and key production and marketing policies are outlined as follows :

  1. Plastics Additives :

(1) Asia :

A. China : Focuses on the industrial applications of polyurethane and polyolefin, targeting the agricultural film, PP woven jumbo bag, and PU foam markets.
B. Korea : Primarily promotes the CN 300 series for wires and cables, and CS B2973 for PP woven jumbo bags.
C. Vietnam : Primarily promotes CS B2973 and its high-concentration masterbatches for PP woven jumbo bags, CS X-100S2 and its high-concentration masterbatches for agricultural films, and additives for polyurethane foam.
D. India : Conducts comprehensive promotion of CS X-100S, CS B2973, and DCHK.

(2) Europe and America : Promote REACH and TSCA registered products, actively develop high-potential customers, and seek new distributor partnerships to enhance product promotion effectiveness.

(3) Maintain relationships with key customers while developing new clients and identifying emerging needs.

  1. UV Curable Materials :

(1) Primarily promote oligomers mass-produced in Dafeng factory for applications in industries such as ink, paint, adhesives, 3D printing, electronics, and contact lenses, etc.

(2) New product promotion : Excimer skin-feel oligomers, flame-retardant resins, stain-resistant resins, and customized formulas.

  1. Digital Textile Materials :

(1) UV absorber for textile : Having obtained Bluesign certification, continuous promotion will be carried out across major markets (China, Southeast Asia, and India).

(2) Turnkey output for digital textile printing and contract development (OEM).

  1. Electronic Materials :

(1) Key 5G / 6G materials: Fully promote to copper-clad laminate (CCL) customers in Taiwan, South Korea, and Japan.

(2) Actively evaluate contract manufacturing (OEM) opportunities for 5G / 6G-related and semiconductor-related materials.

(3) Actively seek electronic sector customers to continuously develop new products.

9


Looking ahead, the global economy still faces numerous uncertainties, and geopolitical risks along with various national economic and trade policies continue to drive global market volatility. To continuously enhance operational resilience, Double Bond Chemical will not only actively develop new products and execute various sales plans to strengthen competitiveness and sustain growth momentum but will also adjust the operational strategy of the Dafeng factory in accordance with the Group's development needs. Meanwhile, the Company will remain committed to increasing in-house production capacity, aiming to achieve more robust development in 5G / 6G and other AI electronic material product sectors, thereby laying a solid foundation for the Company's long-term and steady growth.

Chairman: TSAY, MAW-DER
General Manager: CHEN, CHUNG-PIN
Account Manager: TSAI, JO-YU

10


[Appendix 2]

Audit Committee’s Review Report

The Board of Directors has prepared the Company’s 2025 Business Report, Financial Statements (both parent company only and consolidated), and Profit and Loss Appropriation proposal. Both CPA CHUANG, YEH-WEI & CPA LEE, TUNG-FENG of the CPA firm Deloitte & Touche were retained to audit the Company’s Financial Statements and have issued an audit report relating to the Financial Statements. The Business Report, Financial Statements, and Profit and Loss Appropriation proposal have been reviewed and determined to be correct and accurate by the Audit Committee members of the Company. According to the Securities and Exchange Act and the Company Act, we hereby submit this report.

Double Bond Chemical Ind. Co., Ltd.
Convener of the Audit Committee: TSAI, KAO-CHUNG
March 13, 2026

11


12

【Appendix 3】

Independent Auditors’ Report

The Board of Directors and Shareholders
Double Bond Chemical Ind. Co., Ltd.

Opinion

We have audited the accompanying consolidated financial statements of Double Bond Chemical Ind. Co., Ltd. (the “Company”) and its subsidiaries (the “Group”), which comprise the consolidated balance sheets as of December 31, 2025 and 2024 and the consolidated statements of comprehensive income, changes in equity and cash flows for the years then ended, and notes to the consolidated financial statements, including the summary of significant accounting policies (“collectively referred to as the consolidated financial statements”).

In our opinion, the accompany consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as of December 31, 2025 and 2024, and its consolidated financial performance and its consolidated cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Financial Reporting Standards (IFRS), International Accounting Standards (IAS), IFRIC Interpretations (IFRIC), and SIC Interpretations (SIC) endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Auditing and Attestation of Financial Statements by Certified Public Accountants and auditing standards in the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Group in accordance with The Norm of Professional Ethics for Certified Public Accountant of the Republic of China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements for the year ended December 31, 2025. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.


Key audit matters for the Group’s consolidated financial statements for the year ended December 31, 2025 are stated as follows:

Recognition of Sales Revenue

The Group’s revenue is mainly contributed to from the sale of various chemical raw materials, coating monomers/oligomers, industrial additives, and specialty chemicals. Given the significant fluctuations in major customers and the potential impact of revenue amounts and variances on the users' understanding of the overall financial statements, we have identified the occurrence of revenue from major customers—specifically those with significant year-over-year growth or newly acquired in 2025 as Key Audit Matter. Consequently, we assessed the authenticity of sales revenue from these specific customers as a Key Audit Matter. For accounting policies and information related to revenue recognition, please refer to Notes 4, 22, and 34.

Regarding this Key Audit Matter, our primary audit procedures included:

  1. Understanding and testing the design and operating effectiveness of key internal controls concerning the authenticity of sales revenue from major customers.
  2. Sampling and inspecting transaction documents for major customers, including sales orders and shipping documents.
  3. Sampling and reviewing collections from major customers to verify the authenticity of sales revenue, and confirming whether any significant sales returns occurred after the reporting period to ensure that the operating revenue actually occurred.

Other Matter

We have also audited the parent company only financial statements of the Group as of and for the years ended December 31, 2025 and 2024 on which we have issued an unmodified opinion.

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations and SIC Interpretations endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error. In preparing the consolidated financial statements, management is responsible for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to

13


liquidate the Group or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the supervisors, are responsible for overseeing the Group's financial reporting process.

Auditors' Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with auditing standards in the Republic of China will always detect a material misstatement when its exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit in accordance with auditing standards in the Republic of China, we exercise professional judgment and professional skepticism throughout the audit. We also:

  1. Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omission, misrepresentations, or the override of internal control.
  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group's internal control.
  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
  4. Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our Auditors' report to the related disclosures in the consolidated financial statements or, if such disclosure are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our Auditors' report. However, future events or conditions may cause the Group to cease to continue as a going concern.
  5. Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieve fair presentation.

14


  1. Obtain sufficient and appropriate audit evidence regarding the financial information of entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit and we remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have compiled with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the consolidated financial statements for the year ended December 31, 2025 and are therefore the key audit matters. We describe these matters in our Auditors' report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audit resulting in this independent auditors' report are CHUANG, YEH-WEI and LEE, TUNG-FENG.

Deloitte & Touche
Taipei, Taiwan
Republic of China
March 16, 2026

The accompanying financial statements are intended only to present the financial position, financial performance and cash flows in accordance with accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such financial statements are those generally applied in the Republic of China.


Double Bond Chemical Ind. Co., Ltd. and Subsidiaries
Consolidated Balance Sheets
December 31, 2025 and 2024

(In Thousands of New Taiwan Dollars)

Code Assets December 31, 2025 December 31, 2024
Amount % Amount %
Current Assets
1100 Cash (Note 6) $ 1,101,222 23 $ 1,250,871 26
1136 Financial assets at amortized cost - current (Note 9 & 29) 347,548 7 92,994 2
1150 Notes receivable, net (Note 10 & 22) 37,632 1 50,170 1
1170 Accounts receivable, net (Note 10 & 22) 526,500 11 574,989 12
1180 Accounts receivable from related parties, net (Note 10, 22, 28) 4,033 - 696 -
1200 Other receivables 7,037 - 12,422 -
1220 Current tax assets (Note 24) 225 - 299 -
130X Inventories, net (Note 11) 466,964 10 459,274 9
1479 Other current assets (Note 17, 28, 29) 99,461 2 139,058 3
11XX Total current assets 2,590,622 54 2,580,773 53
Noncurrent Assets
1517 Financial assets at fair value through other comprehensive income - noncurrent
(Note 8) 134,558 3 97,376 2
1600 Property, plant and equipment (Note 13 & 29) 1,801,556 38 1,937,622 40
1755 Right-of-use assets (Note 14 & 28) 18,915 - 24,810 -
1805 Goodwill (Note 15) 26,593 1 26,593 1
1821 Other intangible assets (Note 16) 3,140 - 4,021 -
1840 Deferred tax assets (Note 24) 170,850 4 167,914 3
1915 Prepayments for Business Facilities 3,018 - 2,528 -
1990 Other noncurrent assets (Note 17) 25,751 - 28,760 1
15XX Total noncurrent assets 2,184,381 46 2,289,624 47
1XXX Total assets $ 4,775,003 100 $ 4,870,397 100
Code Liabilities and Equity
Current Liabilities
2100 Short-term borrowings (Note 18 & 29) $ 1,123,717 24 $ 1,097,026 23
2110 Short-term bills payable (Note 18) 149,901 3 59,872 1
2120 Financial liabilities at fair value through profit or loss - current (Note 7) 250 -
2130 Contract liabilities (Note 22) 7,065 - 25,743 1
2150 Notes payable 89,940 2 198,243 4
2160 Notes payable to related parties (Note 28) - - 3,281 -
2170 Accounts payable 213,010 4 197,890 4
2180 Accounts payable to related parties (Note 28) 42,502 1 53,179 1
2219 Other accounts payable (Note 19) 136,080 3 104,502 2
2230 Current tax liabilities (Note 24) 9,987 - 12,276 -
2280 Lease liabilities - current(Note 14 & 28) 631 - 6,026 -
2322 Current portion of long-term borrowings (Note 18 & 29) 128,915 3 239,321 5
2399 Other current liabilities (Note 19) 167 - 2,732 -
21XX Total current liabilities 1,902,165 40 2,000,091 41
Noncurrent liabilities
2540 Long-term borrowings (Note 18 & 29) 513,079 11 654,887 14
2570 Deferred tax liabilities (Note 24) 14,444 - 13,980 -
2580 Lease liabilities - non-current(Note 14 & 28) 209 - 593 -
2640 Net defined benefit liabilities - noncurrent (Note 20) 1,853 - 3,169 -
25XX Total noncurrent liabilities 529,585 11 672,629 14
2XXX Total Liabilities 2,431,750 51 2,672,720 55
Owner's equity of this Company (Note 21)
3110 Common stock 855,421 18 855,421 18
3200 Capital surplus 358,115 7 356,700 7
Retained earnings
3310 Legal reserve 238,077 5 238,077 5
3320 Special reserve 63,242 1 122,999 2
3350 Unappropriated earnings 845,186 18 680,101 14
3300 Total retained earnings 1,146,505 24 1,041,177 21
3490 Other equity (21,120) - (63,242) (1)
31XX Total owner's equity of this Company 2,338,921 49 2,190,056 45
36XX Noncontrolling interest 4,332 - 7,621 -
3XXX Total equity 2,343,253 49 2,197,677 45
Total liabilities and equity $ 4,775,003 100 $ 4,870,397 100

The accompanying notes are an integral part of the consolidated financial statements.


Double Bond Chemical Ind. Co., Ltd. and Subsidiaries

Consolidated Statements of Comprehensive Income

For the Years Ended December 31, 2025 and 2024

(In Thousands of New Taiwan Dollars, Except Loss Per Share)

Code For the Year Ended December 31, 2025 For the Year Ended December 31, 2024
Amount % Amount %
4000 Operating revenue (Note 22 & 28) $ 2,849,976 100 $ 2,702,450 100
5000 Operating costs (Note 11, 23, 28, 30) 2,285,117 80 2,333,972 86
5900 Gross profit 564,859 20 368,478 14
Operating expenses (Note 23 & 28)
6100 Sales and marketing expense 236,020 8 206,943 8
6200 General and administration expense 138,489 5 130,906 5
6300 Research and development expense 66,661 3 57,912 2
6450 (Gain on reversal of) Expected credit loss 892 - (385) -
6000 Total operating expenses 442,062 16 395,376 15
6500 Other operating income and expenses (Note 30) 42,604 2 - -
6900 Net operating profit (loss) 165,401 6 (26,898) (1)
Nonoperating income and expenses (Note 23 & 28)
7100 Interest income 11,493 - 15,329 1
7010 Other income 16,140 1 13,719 1
7020 Other gains and losses (436) - 6,310 -
7050 Financial costs (42,002) (2) (40,573) (2)
7000 Total nonoperating income and expenses (14,805) (1) (5,215) -
7900 Profit (loss) before income tax 150,596 5 (32,113) (1)
7950 Income tax expense (Note 24) 43,230 1 2,590 -
8200 Net profit (loss) for the year 107,366 4 (34,703) (1)

(Carried forward)


(Brought forward)

Code For the Year Ended December 31, 2025 For the Year Ended December 31, 2024
Amount % Amount %
Other comprehensive income (loss)
8310 Items that will not be reclassified subsequently to profit or loss:
8311 Remeasurement of defined benefit plans (Note 20) $ 788 - $ 1,174 -
8316 Unrealized gain or loss on investments in equity instrument at fair value through other comprehensive income 37,182 1 7,726 -
8360 Items that may be reclassified subsequently to profit or loss:
8361 Exchange differences on translating foreign operations 4,943 - 52,139 2
8300 Other comprehensive income (loss) of the year 42,913 1 61,039 2
8500 Total comprehensive income of the year $ 150,279 5 $ 26,336 1
Net profit attributable to:
8610 Owners of the company $ 104,540 4 ($ 37,290) ( 1 )
8620 Non-controlling interests 2,826 - 2,587 -
8600 $ 107,366 4 ($ 34,703) ( 1 )
Comprehensive income attributable to:
8710 Owners of the company $ 147,450 5 $ 23,641 1
8720 Non-controlling interests 2,829 - 2,695 -
8700 $ 150,279 5 $ 26,336 1
Earnings (loss) per share (Note 25)
9750 Basic $ 1.22 ($ 0.44 )
9850 Diluted $ 1.22 ($ 0.44 )

The accompanying notes are an integral part of the consolidated financial statements.


Double Bond Chemical Ind. Co., Ltd. and Subsidiaries
Consolidated Statements of Changes in Equity
For the Years Ended December 31, 2025 and 2024
(In Thousands of New Taiwan Dollars)

Code Ordinary Shares (Note 20) Retained Earnings (Note 20) Other Equity
Number of Shares (thousand) Amount Capital Surplus (Note 20) Legal Reserve Special Reserve Unappropriated Earnings Minor Sum Exchange Differences on Translating Foreign Operations Unrealized gain (loss) on financial assets at fair value through other comprehensive income) Minor Sum Total Noncontrolling Interest Total Equity
A1 Balance as of January 1, 2024 85,542 $ 855,421 $ 356,590 $ 238,077 $ 77,883 $ 761,333 $1,077,293 ( $ 172,299 ) $ 49,300 ( $ 122,999 ) $2,166,305 $ 4,926 $2,171,231
B3 Appropriation of 2023 earnings Special reserve - - - - 45,116 ( 45,116 ) - - - - - - -
C17 Other changes in capital surplus - - 110 - - - - - - - 110 - 110
D1 Net profit for the year ended December 31, 2024 - - - - - ( 37,290 ) ( 37,290 ) - - - ( 37,290 ) 2,587 ( 34,703 )
D3 Other comprehensive income (loss) after tax for the year ended December 31, 2024 - - - - - 1,174 1,174 52,031 7,726 59,757 60,931 108 61,039
D5 Total comprehensive income (loss) for the year ended December 31, 2024 - - - - - ( 36,116 ) ( 36,116 ) 52,031 7,726 59,757 23,641 2,695 26,336
Z1 Balance as of December 31, 2024 85,542 855,421 356,700 238,077 122,999 680,101 1,041,177 ( 120,268 ) 57,026 ( 63,242 ) 2,190,056 7,621 2,197,677
B17 Appropriation of 2024 earnings eversal of special reserve - - - - ( 59,757 ) 59,757 - - - - - - -
D1 Net profit for the year ended December 31, 2025 - - - - - 104,540 104,540 - - - 104,540 2,826 107,366
D3 Other comprehensive income (loss) after tax for the year ended December 31, 2025 - - - - - 788 788 4,940 37,182 42,122 42,910 3 42,913
D5 Total comprehensive income (loss) for the year ended December 31, 2025 - - - - - 105,328 105,328 4,940 37,182 42,122 147,450 2,829 150,279
M5 Acquisition of partial interests in subsidiaries - - 1,415 - - - - - - - 1,415 ( 4,545 ) ( 3,130 )
O1 Changes in non-controlling interests - - - - - - - - - - - ( 1,573 ) ( 1,573 )
Z1 Balance as of December 31, 2025 85,542 $ 855,421 $ 358,115 $ 238,077 $ 63,242 $ 845,186 $1,146,505 ( $ 115,328 ) $ 94,208 ( $ 21,120 ) $2,338,921 $ 4,332 $2,343,253

The accompanying notes are an integral part of the consolidated financial statements.


Double Bond Chemical Ind. Co., Ltd. and Subsidiaries
Consolidated Statements of Cash Flows
For the Years Ended December 31, 2025 and 2024
(In Thousands of New Taiwan Dollars)

Code Cash Flows from Operating Activities For the Year Ended December 31, 2025 For the Year Ended December 31, 2024
A00010 Profit (loss) before income tax $ 150,596 ( $ 32,113 )
A20010 Adjustments for:
A20100 Depreciation expense 170,412 173,326
A20200 Amortization expense 5,911 5,021
A20300 (Gain on reversal of) Expected credit loss 892 ( 385 )
A20400 Net loss on fair value changes of financial assets and liabilities at fair value through profit or loss 785 -
A20900 Financial cost 42,002 40,573
A21200 Interest income ( 11,493 ) ( 15,329 )
A21300 Dividend revenue ( 2,112 ) ( 2,112 )
A22500 Loss on disposal of property, plant and equipment 757 2,017
A23800 Gain on reversal of market price decline and obsolete and slow-moving inventories ( 9,681 ) ( 5,336 )
A24100 Unrealized gain on foreign exchange ( 5,720 ) ( 208 )
A29900 Fire loss - 62,832
A29900 Loss on lease modification - 2
A30000 Net changes in operating assets and liabilities
A31110 Financial assets and liabilities at fair value through profit or loss ( 535 ) -
A31130 Notes receivable 12,335 ( 2,289 )
A31150 Accounts receivable 55,267 ( 173,257 )
A31160 Accounts receivable from related parties ( 3,201 ) 4,234
A31180 Other receivable 5,545 22,357
A31200 Inventories 2,333 ( 131,406 )
A31240 Other current assets 38,021 ( 21,666 )
A32125 Contract liabilities ( 18,674 ) 8,655
A32130 Notes payable ( 105,144 ) 68,001
A32140 Notes payable to related parties ( 3,175 ) ( 1,191 )
A32150 Accounts payable 13,589 27,853
A32160 Accounts payable to related parties ( 10,487 ) 15,134
A32180 Other accounts payable 31,571 20,918

(Carried forward)


(Brought forward)

Code For the Year Ended December 31, 2025 For the Year Ended December 31, 2024
A32230 Other current liabilities ($ 2,616) $ 1,699
A32240 Net defined benefit liabilities ( 528) ( 815)
A33000 Cash generated from operating activities 356,650 66,515
A33100 Interest received 11,489 15,328
A33200 Stock dividend received 2,112 2,112
A33300 Interest paid ( 42,604) ( 40,018)
A33500 Income taxes paid ($ 47,067) ( 40,248)
AAAA Net cash generated from operating activities 280,580 3,689
Cash Flows from Investing Activities
B00040 Increase in financial assets at amortized cost ( 245,158) ( 89,512)
B02700 Purchase of property, plant and equipment ( 25,007) ( 26,626)
B02800 Disposal of property, plant and equipment 138 1,349
B04500 Purchase of intangible assets ( 55) ( 38)
B07100 Decrease (Increase) in prepayments for business facilities ( 4,752) 32
B06700 Decrease (Increase) in other noncurrent assets ( 1,971) 23
BBBB Net cash used in investing activities ( 276,805) ( 114,772)
Cash Flows from Financing Activities
C00500 Increase in short-term bills payable 90,029 59,872
C00100 Increase in short-term borrowings 26,691 242,026
C01600 Decrease in long-term borrowings ( 252,209) ( 163,472)
C04020 Repayments of lease liabilities ( 5,884) ( 5,780)
C05400 Acquisition of additional interests in subsidiary ( 3,130) -
C05800 Dividends paid to non-controlling interests ( 1,573) -
C09900 Other changes in capital surplus - 110
CCCC Net cash generated from (used in) financing activities ( 146,076) 132,756
DDDD Impact of changes in exchange rate on cash ( 7,348) 33,205
EEEE Net increase (decrease) in cash of the year ( 149,649) 54,878
E00100 Cash at the beginning of the year 1,250,871 1,195,993
E00200 Cash at the end of the year $1,101,222 $1,250,871

The accompanying notes are an integral part of the consolidated financial statements.


22

【Appendix 4】

Independent Auditors’ Report

The Board of Directors and Shareholders
Double Bond Chemical Ind. Co., Ltd.

Opinion

We have audited the accompanying financial statements of Double Bond Chemical Ind. Co., Ltd. (the Company), which comprise the balance sheets as of December 31, 2025 and 2024 and the statements of comprehensive income, changes in equity and cash flows for the years then ended, and notes to the individual financial statements, including the summary of significant accounting policies.

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and its financial performance and its cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Auditing and Attestation of Financial Statements by Certified Public Accountants and auditing standards in the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with The Norm of Professional Ethics for Certified Public Accountant of the Republic of China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements for the year ended December 31, 2025. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Key audit matters for the Company’s financial statements for the year ended December 31, 2025 are stated as follows:

Recognition of Sales Revenue


The Company's revenue is mainly contributed to from the sale of various chemical raw materials, coating monomers/oligomers, industrial additives, and specialty chemicals. Given the significant fluctuations in major customers and the potential impact of revenue amounts and variances on the users' understanding of the overall financial statements, we have identified the occurrence of revenue from major customers—specifically those with significant year-over-year growth or newly acquired in 2025 as Key Audit Matter. Consequently, we assessed the authenticity of sales revenue from these specific customers as a Key Audit Matter. For accounting policies and information related to revenue recognition, please refer to Notes 4, and 21.

Regarding this Key Audit Matter, our primary audit procedures included:

  1. Understanding and testing the design and operating effectiveness of key internal controls concerning the authenticity of sales revenue from major customers.
  2. Sampling and inspecting transaction documents for major customers, including sales orders and shipping documents.
  3. Sampling and reviewing collections from major customers to verify the authenticity of sales revenue, and confirming whether any significant sales returns occurred after the reporting period to ensure that the operating revenue actually occurred

Responsibilities of Management and Those Charged with Governance for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the supervisors, are responsible for overseeing the Company's financial reporting process.

Auditors' Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but


is not a guarantee that an audit conducted in accordance with auditing standards in the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

As part of an audit in accordance with auditing standards in the Republic of China, we exercise professional judgment and professional skepticism throughout the audit. We also:

  1. Identify and assess the risks of material misstatement of the individual financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control.
  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
  4. Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors' report to the related disclosures in the financial statements or, if such disclosure are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors' report. However, future events or conditions may cause the Company to cease to continue as a going concern.
  5. Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the individual financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
  6. Obtain sufficient and appropriate audit evidence on the financial information of the entities or business activities within the Company to express an opinion on the financial statements. We are responsible for the direction, supervision and performance of the group audit and we remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have compiled with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence,

24


and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements for the year ended December 31, 2025 and are therefore the key audit matters. We describe these matters in our auditors' report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audit resulting in this independent auditors' report are CHUANG,YEH-WEI and LEE,TUNG-FENG.

Deloitte & Touche
Taipei, Taiwan
Republic of China
March 16, 2026

The accompanying financial statements are intended only to present the financial position, financial performance and cash flows in accordance with accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such financial statements are those generally applied in the Republic of China.

25


Double Bond Chemical Ind. Co., Ltd.
Balance Sheets
December 31, 2025 and 2024
(In Thousands of New Taiwan Dollars)

Code Assets December 31, 2025 December 31, 2024
Amount % Amount %
Current Assets
1100 Cash (Note 6) $ 269,754 6 $ 231,089 5
1136 Financial assets at amortized cost - current (Note 9 & 28) 8,000 - 3,000 -
1150 Notes receivable, net (Note 10 & 21) 7,337 - 9,994 -
1170 Accounts receivable, net (Note 10 & 21) 227,813 5 194,295 5
1180 Accounts receivable from related parties, net (Note 10, 21 & 27) 118,070 3 98,768 2
1200 Other receivables 621 - 8,806 -
1210 Other receivables from related parties, net (Note 27) 412 - 8,478 -
1220 Current tax assets (Note 23) 135 - 299 -
130X Inventories, net (Note 11) 263,437 6 268,352 6
1479 Other current assets (Note 16) 31,474 1 23,597 1
11XX Total current assets 927,053 21 846,678 19
Noncurrent Assets
1517 Financial assets at fair value through other comprehensive income - noncurrent (Note 8) 134,558 3 97,376 2
1550 Investments accounted for using equity method (Note 12) 1,704,922 38 1,645,078 37
1600 Property, plant and equipment (Note 13 & 28) 1,669,137 37 1,788,928 40
1821 Other intangible assets (Note 15) 3,133 - 4,013 -
1840 Deferred tax assets (Note 23) 53,299 1 61,213 2
1915 Prepayments for Business Facilities 952 - 1,321 -
1990 Other noncurrent assets (Note 16) 14,021 - 16,164 -
15XX Total noncurrent assets 3,580,022 79 3,614,093 81
1XXX Total assets $ 4,507,075 100 $ 4,460,771 100
Liabilities and Equity
Current Liabilities
2100 Short-term borrowings (Note 17 & 28) $ 1,123,717 25 $ 1,097,026 25
2110 Short-term bills payable (Note 17) 149,901 3 59,872 1
2120 Financial liabilities at fair value through profit or loss - current (Note 7) 250 - - -
2130 Contract liabilities (Note 21) 3,962 - 22,235 1
2150 Notes payable 20 - 14 -
2170 Accounts payable 81,300 2 66,230 2
2180 Accounts payable to related parties (Note 27) 68,026 1 50,271 1
2219 Other accounts payable (Note 18 & 27) 83,361 2 57,256 1
2322 Current portion of long-term borrowings (Note 17 & 28) 128,805 3 239,321 5
2399 Other current liabilities (Note 18) 18 - 20 -
21XX Total current liabilities 1,639,360 36 1,592,245 36
Noncurrent liabilities
2540 Long-term borrowings (Note 17 & 28) 513,079 12 654,829 15
2570 Deferred tax liabilities (Note 23) 13,705 - 12,740 -
2640 Net defined benefit liabilities - noncurrent (Note 19) 1,853 - 3,169 -
2670 Other noncurrent liabilities (Note 12) 157 - 7,732 -
25XX Total noncurrent liabilities 528,794 12 678,470 15
2XXX Total Liabilities 2,168,154 48 2,270,715 51
Owner's equity of this Company (Note 20)
3110 Capital stock 855,421 19 855,421 19
3200 Capital surplus 358,115 8 356,700 8
Retained earnings
3310 Legal reserve 238,077 5 238,077 5
3320 Special reserve 63,242 1 122,999 3
3350 Unappropriated earnings 845,186 19 680,101 15
3300 Total retained earnings 1,146,505 25 1,041,177 23
3490 Other equity ( 21,120 ) - ( 63,242 ) ( 1 )
3XXX Total equity 2,338,921 52 2,190,056 49
Total liabilities and equity $ 4,507,075 100 $ 4,460,771 100

The accompanying notes are an integral part of the financial statements.


Double Bond Chemical Ind. Co., Ltd.
Statements of Comprehensive Income
For the Years Ended December 31, 2025 and 2024
(In Thousands of New Taiwan Dollars, Except Earnings (Loss) Per Share)

Code For the Year Ended December 31, 2025 For the Year Ended December 31, 2024
Amount % Amount %
4000 Operating revenue (Note 21 & 27) $ 1,535,322 100 $ 1,202,421 100
5000 Operating costs (Note 11, 22, 27 & 29) 1,272,289 83 1,141,571 95
5900 Gross profit 263,033 17 60,850 5
5910 Realized (unrealized) gain from sale 90 - ( 7,525 ) ( 1 )
5950 Gross profit and realized gain 263,123 17 53,325 4
Operating expenses (Note 14, 19, 22 & 27)
6100 Sales and marketing expense 139,009 9 95,447 8
6200 General and administration expense 70,674 5 58,810 5
6300 Research and development expense 54,308 3 46,119 4
6000 Total operating expenses 263,991 17 200,376 17
6500 Other operating income and expenses (Note 29) 42,604 3 - -
6900 Net operating profit (loss) 41,736 3 ( 147,051 ) ( 12 )
Nonoperating income and expenses
7100 Interest income (Note 22 & 27) 1,906 - 2,611 -
7010 Other income (Note 22) 9,413 1 5,865 -
7020 Other gains and losses (Note 22) 3,743 - 10,925 1
7050 Financial costs (Note 22) ( 41,840 ) ( 3 ) ( 40,180 ) ( 3 )
7070 Share of profit or loss of subsidiaries, associates, and joint ventures accounted for using the equity method (Note 12) 103,070 7 101,172 8
7000 Total nonoperating income and expenses 76,292 5 80,393 7
7950 Income tax expense (revenue) (Note 23) 13,488 1 ( 29,368 ) ( 2 )
8200 Net profit (loss) for the year 104,540 7 ( 37,290 ) ( 3 )

(Carried forward)

(Brought forward)


Code For the Year Ended December 31, 2025 For the Year Ended December 31, 2024
Amount % Amount %
8310 Other comprehensive income (loss)
8311 Items that will not be reclassified subsequently to profit or loss:
8316 Remeasurements of defined benefit plans (Note 19) $ 788 - $ 1,174 -
8316 Unrealized gain or loss on investments in equity instrument at fair value through other comprehensive income 37,182 3 7,726 1
8360 Items that may be reclassified subsequently to profit or loss:
8361 Exchange differences on translating foreign operations 4,940 - 52,031 4
8300 Other comprehensive income (loss) of the year 42,910 3 60,931 5
8500 Total comprehensive income of the year $ 147,450 10 $ 23,641 2
Earnings (loss) per share (Note 24)
9750 Basic $ 1.22 ($ 0.44)
9850 Diluted $ 1.22 ($ 0.44)

The accompanying notes are an integral part of the financial statements.


Double Bond Chemical Ind. Co., Ltd.
Statements of Changes in Equity
For the Years Ended December 31, 2025 and 2024
(In Thousands of New Taiwan Dollars)

Code Ordinary Shares (Note 19) Retained Earnings (Note 19) Other Equity
Number of Shares (thousand) Amount Capital Surplus (Note4 & 19) Legal Reserve Special Reserve Unappropriated Earnings Minor Sum Exchange Differences on Translating Foreign Operations Unrealized gain (loss) on financial assets at fair value through other comprehensive income(Note 4) Minor Sum Total Equity
A1 Balance as of January 1, 2024 85,542 $855,421 $356,590 $238,077 $77,883 $761,333 $1,077,293 ($172,299) $49,300 ($122,999) $2,166,305
B3 Appropriation of 2023 earnings Special reserve - - - - 45,116 (45,116) - - - - -
C17 Other changes in capital surplus - - 110 - - - - - - - 110
D1 Net profit for the year ended December 31, 2024 - - - - - (37,290) (37,290) - - - (37,290)
D3 Other comprehensive income (loss) after tax for the year ended December 31, 2024 - - - - - 1,174 1,174 52,031 7,726 59,757 60,931
D5 Total comprehensive income (loss) for the year ended December 31, 2024 - - - - - (36,116) (36,116) 52,031 7,726 59,757 23,641
Z1 Balance as of December 31, 2024 85,542 855,421 356,700 238,077 122,999 680,101 1,041,177 (120,268) 57,026 (63,242) 2,190,056
B17 Appropriation of 2024 earnings Reversal of special reserve - - - - (59,757) 59,757 - - - - -
D1 Net profit for the year ended December 31, 2025 - - - - - 104,540 104,540 - - - 104,540
D3 Other comprehensive income (loss) after tax for the year ended December 31, 2025 - - - - - 788 788 4,940 37,182 42,122 42,910
D5 Total comprehensive income (loss) for the year ended December 31, 2025 - - - - - 105,328 105,328 4,940 37,182 42,122 147,450
M5 Acquisition of partial interests in subsidiaries - - 1,415 - - - - - - - 1,415
O1 Changes in non-controlling interests - - - - - - - - - - -
Z1 Balance as of December 31, 2025 85,542 $855,421 $358,115 $238,077 $63,242 $845,186 $1,146,505 ($115,328) $94,208 ($21,120) $2,338,921

The accompanying notes are an integral part of the financial statements.


Double Bond Chemical Ind. Co., Ltd.
Statements of Cash Flows
For the Years Ended December 31, 2025 and 2024

| Code | Cash Flows from Operating Activities | (In Thousands of New Taiwan Dollars)
For the Year Ended December 31, 2025 | For the Year Ended December 31, 2024 |
| --- | --- | --- | --- |
| A00010 | Loss before income tax | $ 118,028 | ($ 66,658) |
| A20010 | Adjustments for: | | |
| A20100 | Depreciation expense | 142,765 | 142,911 |
| A20200 | Amortization expense | 3,112 | 2,981 |
| A20400 | Net loss on fair value changes of financial assets and liabilities at fair value through profit or loss | 785 | - |
| A20900 | Financial cost | 41,840 | 40,180 |
| A21200 | Interest income | ( 1,906 ) | ( 2,611 ) |
| A21300 | Dividend revenue | ( 2,112 ) | ( 2,112 ) |
| A22300 | Share of profits or losses of subsidiaries and associates accounted for using the equity method | ( 103,070 ) | ( 101,172 ) |
| A22500 | Gain (Loss) on disposal of property, plant and equipment | 759 | 2,866 |
| A23800 | Loss for (Gain on reversal of) market price decline and obsolete and slow-moving inventories | ( 3,814 ) | ( 16,339 ) |
| A23900 | Unrealized (Realized) gain on transactions with subsidiaries | ( 90 ) | 7,525 |
| A24100 | Unrealized gain on foreign exchange | ( 5,720 ) | ( 259 ) |
| A29900 | Fire loss | - | 62,832 |
| A30000 | Net changes in operating assets and liabilities | | |
| A31110 | Financial assets and liabilities at fair value | ( 535 ) | - |
| A31130 | Notes receivable | 2,657 | 1,198 |
| A31150 | Accounts receivable | ( 26,846 ) | ( 86,437 ) |
| A31160 | Accounts receivable from related parties | ( 19,302 ) | ( 25,152 ) |
| A31180 | Other receivable | 8,188 | 21,794 |
| A31200 | Inventories | 8,729 | ( 112,404 ) |
| A31240 | Other current assets | ( 7,877 ) | ( 2,983 ) |
| A32125 | Contract liabilities | ( 18,273 ) | 19,476 |
| A32130 | Notes payable | 6 | - |
| A32150 | Accounts payable | 14,119 | 11,576 |
| A32160 | Accounts payable to related parties | 17,755 | 101 |

(Carried forward)
30


(Brought forward)

Code For the Year Ended December 31, 2025 For the Year Ended December 31, 2024
A32180 Other accounts payable 26,707 19,282
A32230 Other current liabilities ( 2 ) 2
A32240 Net defined benefit liabilities ( 528 ) ( 815 )
A33000 Cash generated from (used in) operating activities 195,375 ( 84,218 )
A33100 Interest received 1,903 2,610
A33200 Stock dividend received 2,112 2,112
A33300 Interest paid ( 42,442 ) ( 39,625 )
A33500 Income taxes paid (received) ( 4,445 ) 4,955
AAAA Net cash generated from (used in) operating activities 152,503 ( 114,166 )
Cash Flows from Investing Activities
B00040 Increase in financial assets at amortized cost ( 5,000 ) -
B02700 Purchase of property, plant and equipment ( 19,442 ) ( 22,894 )
B02800 Disposal of property, plant and equipment 7 131
B03700 Decrease (increase) in refundable deposits ( 33 ) 196
B04500 Purchase of intangible assets ( 55 ) ( 38 )
B05900 Decrease in other receivables from related parties 8,066 4,197
B07100 Increase in prepayments for business facilities ( 3,929 ) ( 235 )
B07600 Collection of subsidiary stock dividends 45,221 44,610
BBBB Net cash generated from investing activities 24,835 25,967
Cash Flows from Financing Activities
C00500 Increase in short-term bills payable 90,029 59,872
C00100 Increase in short-term borrowings 26,691 242,026
C05400 Acquisition of additional interests in ( 3,127 ) ( 4,852 )
C01600 Decrease in long-term borrowings ( 252,266 ) ( 163,122 )
C09900 Other changes in capital surplus - 110
CCCC Net cash generated from (used in) financing ( 138,673 ) 134,034
EEEE Net increase in cash of the year 38,665 45,835
E00100 Cash at the beginning of the year 231,089 185,254
E00200 Cash at the end of the year $ 269,754 $ 231,089

The accompanying notes are an integral part of the financial statements.


【Appendix 5】

Double Bond Chemical Ind. Co., Ltd. 2025 Earnings Distribution Table

Unit: NT$

Item Amount
Undistributed earnings, beginning of the year 739,856,222
Net profit after tax of the year 104,539,815
Reassessment value of the defined benefit plans recognized in retained earnings 788,183
The net profit after tax is added to the amount of items other than the net profit after tax of the current period included in the undistributed surplus of the current year 105,327,998
Appropriation
Appropriate legal reserves (10%) (10,532,800)
Reversal of special reserve 42,122,221
Distributable earnings for the year 876,773,641
Distribution
Cash dividends for shareholders (NT$1) (85,542,062)
Undistributed Earnings, end of the year 791,231,579

Chairman: TSAY, MAW-DER
General Manager: CHEN, CHUNG-PIN
Account Manager: TSAI, JO-YU


[Appendix 6]
The list of candidates for directors and independent directors

Title Name Education Experience Number of shares held
Director LEE, KUN-CHANG Bachelor of Department of Chemistry, National Central University • General Manager of HG CO., LTD.
• Director of SIN HUN CHEMICAL CO., LTD.
• Supervisor of FDC, Lees Co., Ltd.
• Supervisor of RUYU CO., LTD.
• Chairperson of BEST ROUND CO., LTD.
• Chairperson of CPCO CO., LTD. 6,757,320
Director LIN, LIANG National Taiwan University EMBA • Chairperson of JATDIX INVESTMENTS INTERNATIONAL LIMITED
• Corporate representative chairperson of Innonyx International Co., Ltd.
• Chairperson of JATDIA international Business Co., Ltd.
• Supervisor of ACCE Biotech Company Limited
• Corporate representative director of VisionaryBioMed Limited
• Corporate representative director of T-BAL CO., LTD.
• Chairperson & general manager of Double Bond Chemical Ind. Co., Ltd.
• Product manager of NICE ENTERPRISE CO., LTD. 1,184,683

Title Name Education Experience Number of shares held
Director Representative of Jatdix Investments International Limited LIU, CHIEN-LIANG Bachelor of Department of Chemistry, National Taiwan University of Science and Technology • Director of JATDIX INVESTMENTS INTERNATIONAL LIMITED
• Supervisor of T-BAL CO., LTD.
• Corporate representative director of Innonyx International Co., Ltd.
• Supervisor of JATDITA Investments Co., Ltd.
• Director of ACCE Biotech Company Limited
• Director of Circular Power Biotech Biology Co., Ltd.
• Supervisor of Green Carbon Sustainability Technology Co., Ltd.
• Chairperson & general manager of Double Bond Chemical Ind. Co., Ltd.
• Chairperson of SIN HUN CHEMICAL CO., LTD.
• Director of GLYCONEX INC.
• General manager of UCB company 8,493,770
Director TSAY, MAW-DER Bachelor of Department of textile science, National Taipei University of Technology • General manager of Double Bond Chemical Ind. Co., Ltd.
• Business manager of EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION 2,959,372
Independent director LEE, SHUEI-SHENG Bachelor of Department of Accounting, National Cheng Kung University • Auditor of Bank of Taiwan
• Deputy manager of South Africa branch and Gaorong Branch, Bank of Taiwan 132,220

Title Name Education Experience Number of shares held
Independent director CHANG, SHU-MEI PhD in Chemistry, University of Cambridge, UK
Master of Chemistry, Imperial College London
Bachelor of Science in Chemistry, National Taiwan University • Professor of Molecular Science and Engineering, National Taipei University of Technology
• Supervisor of Taiwan Textile Research Institute
• Supervisor of The Society of Taiwan Women in Science and Technology 8,805
Independent director WANG, CHING-CHEN China Maritime College, Marine Engineering Department • Chairperson of Sun Co., Ltd -
Independent director WANG, REN-CHAIN Ph.D. in Chemistry, University of Illinois, USA
Bachelor of Science in Chemistry, Soochow University, Taiwan • General Director of Green Energy and Environment Research Laboratories, Industrial Technology Research Institute
• Vice President of Chitec Technology Co., Ltd.
• Senior Researcher, Shell Oil Company, USA -

35


{Annex 1}

Double Bond Chemical Ind. Co., Ltd.
Articles of Incorporation

Chapter 1 General Provision

Article 1 The Company, Double Bond Chemical Ind. Co., Ltd., was incorporated pursuant to provisions of the Company Act.

Article 2 The Company is engaged in the following business operations:

  1. F108031 Wholesale of Medical Devices
  2. F208031 Retail Sale of Medical Apparatus
  3. ZZ99999 All business items that are not prohibited or restricted by law, except those that are subject to special approval.

Article 2-1 The Company is required to provide external guarantee only to its affiliates.

Article 3 The Company is headquartered in New Taipei City, Taiwan. Branches, offices, and business premises may be set up at home and aboard as necessary after a resolution is made by the meeting of the board of directors.

Article 4 The Company’s means of announcement shall be in accordance with Article 28 of the Company Act.

Chapter 2 Shares

Article 5 The Company’s capital is rated at NT$1.2 billion, which is divided into 120 million shares at NT$10 per share; the Company authorizes the board of directors to issue the shares in batches when necessary. The Company may, within the range of total capital thereof, reserve 40 million shares, which are divided into 4 million shares at NT$10 per share, to be issued as employee stock option certificates, which may be issued in batches based on the resolution made by the meeting of the board of directors.

Article 6 Deleted.

Article 7 The Company is exempted from printing any share certificate for the shares to be issued to the public, provided that the Company shall appoint a centralized securities custody enterprise/institution to make recordation of the issue of such shares.

Article 8 Registration for transfer of shares shall be suspended for a period of 60 days prior to the annual general meeting, 30 days before the convening date of a special shareholders meeting, or within 5 days before the date on which dividends, bonus, or other benefits are scheduled to be paid by the Company, pursuant to the relevant laws and regulations and the regulations of the competent authority.

Chapter 3 Shareholders’ Meeting

Article 9 Shareholders’ meeting shall be of the following two kinds: regular meetings of shareholders and special meetings of shareholders. Regular meetings of shareholders,

36


which shall be held at least once every year and convened by the board of directors within 6 months after close of each fiscal year, while special meetings of shareholders shall be held when necessary.

Article 9-1 The Company's shareholders' meetings may be conducted through video conferences or other manners announced by central competent authority.

Article 10 A shareholder may, when unable to attend the shareholders' meeting for any reason, appoint a proxy pursuant to Article 177 of the Company Act and the “Regulations Governing the Use of Proxies for Attendance at Shareholder Meetings of Public Companies” announced by the competent authority to attend in his/her/its behalf by executing a power of attorney printed by the Company stating therein the scope of power authorized to the proxy with the shareholders' signature and/or seal affixed thereto.

Article 11 A shareholder shall have one voting power in respect of each share in his/her/its possession, but the shares held by the Company itself in accordance with Article 179 of the Company Act have no voting power.

Article 12 Resolutions at a shareholders' meeting shall, unless otherwise provided for in the Company Act, be adopted by a majority vote of the shareholders present, who represent more than one-half of the total number of voting shares. The Company's shareholders may exercise his/her voting power by way of electronic transmission and a shareholder who exercises his/her voting power at a shareholder meeting by way of electronic transmission shall be deemed to have attended the said shareholders' meeting in person and processed pursuant to laws and regulations.

Article 12-1 Resolutions adopted at a shareholders' meeting shall be recorded in the minutes of the meeting, which shall be affixed with the signature or seal of the chairman of the meeting and shall be distributed to all shareholders of the company within twenty (20) days after the close of the meeting. The meeting agenda of the shareholders' meeting shall be kept in the Company together with the attendance cards of the attendees of the shareholders and the power of attorney for the proxies to attend the meeting. The production and distribution of the meeting agenda in the preceding paragraph can be done electronically while the distribution of the meeting agenda in the preceding paragraph can be announced publicly.

Article 12-2 To revoke the public issuance of the Company's shares, the Company shall have this case approved and passed by the special resolutions made in the shareholders meetings which shall remain unchanged throughout the emerging and listing period.

Article 13 Deleted.

Chapter 4 Board of Directors and Audit Committee

Article 14 The Company shall have five (5) to nine (9) directors to be elected at a shareholder

37


meeting through candidates nominating system from the nominees listed to serve a term of three years. A director may be re-elected, and the aforesaid board of directors must have at least three (3) and one-fifth (1/5) independent directors of all directors. Election of independent directors shall adopt the candidate nomination measure, and independent directors shall be elected from among the list of candidates for independent directors by the shareholders' meeting. Matters regarding professional qualification, restrictions on shareholdings, concurrent positions held, determination of independency, method of nomination and election and other matters for compliance with respect to independent directors shall be subject to the rules prescribed by the securities governing authorities. The directors adopt the candidate nomination system according to Article 192-1 of the Company Act, for which the nomination of director candidates and matters related to the announcement shall be handled in accordance with the Company Act, the Securities & Exchange Act, and other relevant laws and regulations.

The company sets up an audit committee consisting of only independent directors in accordance with the provisions of the Securities and Exchange Act. And the functions of the Audit Committee and other matters to be followed shall be handled in accordance with the provisions of the Company Law, the Securities Exchange Law, other relevant laws and regulations and articles of incorporation.

The audit committee shall consist of at least 1 out of 3 independent directors with accounting or financial expertise, and one of them shall act as the convener.

Article 14-1 In the process of electing directors at a shareholders' meeting, the number of votes exercisable in respect of one share shall be the same as the number of directors to be elected, and the total number of votes per share may be consolidated for election of one candidate or may be split for election of two or more candidates. A candidate to whom the ballots cast represent a prevailing number of votes shall be deemed a director elect.

Article 14-2 The Company shall take out supervisors' liability insurance with respect to liabilities resulting from the directors' exercise of duties during their terms

Article 15 Composed of directors, the board of directors shall, from among the directors by a majority vote at a meeting attended by over two-thirds of the directors, elect a chairman of the board directors to represent the company externally

Article 16 When the Chairman takes leave or fails to exercise his authority for any reason, his proxy shall deal with the situation pursuant to Article 208 of the Company Act. In case a director is unable to attend a meeting of the board of the directors, he/she may appoint another directors to attend the meeting in his/her behalf, where he/she shall, in each time, issue a written proxy and state therein the scope of authority with reference to the

38


subjects to be discussed at the meeting. In case a meeting of the board of directors is proceeded via visual communication network, then the directors taking part in such a visual communication meeting shall be deemed to have attended the meeting in person.

Article 17 The remuneration of all directors is subject to be authorized by the board of directors, which shall be determined based on the degree of participation and contributions of the directors to the Company’s operations as well as the level of remuneration normally paid by the industry.

Chapter 5 Managerial Personnel

Article 18 The Company has established managerial personnel, and its appointments, dismissal, and remuneration are handled in accordance with the provisions set forth in Article 29 of the Company Act.

Chapter 6 Accounting

Article 19 At the close of each fiscal year, the Company’s board of directors shall prepare the following statements and records and shall forward the same to the shareholders meeting for its auditing:

  1. The business report;
  2. The financial statements; and
  3. The surplus earning distribution or loss off-setting proposals

Article 20 If the Company is profitable in the year, it shall allocate no less than 1% for the employees’ compensation and no more than 5% for the directors’ remuneration, both of which shall be issued in cashes based on the resolutions made by the board of directors. However, if the Company has accumulated losses, it should retain the amount of compensation in advance before paying the employees’ compensation and the directors’ remuneration according to the proportion set forth in the preceding paragraph.

At least 50% of the employee compensation amount referred to in the preceding paragraph shall be allocated to non-executive employees.

The distribution plans for employee and director remuneration shall be reported to the shareholders’ meeting.

When the company distributes the earnings after the end of each half of the fiscal year, it shall firstly retain the employees’ compensation and the directors’ remuneration according to the proportion set forth in the article. When the company has accumulated losses, it shall also retain the amount of compensation in advance before retaining the employees’ compensation and the directors’ remuneration according to the provisions of this article.

The company's executive treasury shares, employee stock option vouchers, employee acquisition of new shares, restrictions on employee rights, new shares and employee

39


compensation, etc., shall include control or subordinate company employees who meet certain conditions.

Article 21 The Company shall, if there is surplus earning upon annual closing, pay regulatory taxes and off-set accumulated losses before listing 10% to the statutory surplus reserve, provided that, the statutory surplus reserve will no longer need to be listed if it has reached the amount equal to that of the Company’s paid-in capital, and the remaining balance shall be listed or reverse special reserve pursuant to law. The board of directors shall consolidate any remaining balance with the accumulated undistributed earnings into a Surplus Earning Distribution Proposal and present it in the shareholders’ meeting for a resolution on the distribution of dividends.

Stock dividends, legal reserves, and capital reserves are issued in cash according to the preceding paragraph upon resolution adopted by a majority vote at a meeting of board of directors in which at least 2/3 directors are authorized to attend.

The Company is currently developing steadily in an industry that is now growing and expanding. Since R&D and capacity upgrade are important factors for competitiveness and sustainable operation that require a steady source of investment, the current stage of the company’s dividend policy is based on the company’s attempted capital budget planning to measure the annual funding needs, after which the Company adopts part of the stock dividends to retain the funds required for the Company’s operations. However, if the profitability is significantly diluted, the Board of Directors will refer to the operating and capital expenditures and the shareholders’ demand for cash inflows to formulate appropriate ratios of cash and stock dividends, among which cash dividends account for no less than 10% of the total dividends.

Article 21-1 The Company may distribute surplus earnings or make up for losses after the end of each half of the fiscal year and the board of directors shall prepare the books, bills, and proposals before submitting them to the audit committee for review.

The Company shall, if there is surplus earning upon annual closing, pay regulatory taxes and off-set accumulated losses before listing the statutory surplus reserve, provided that, the statutory surplus reserve will no longer need to be listed if it has reached the amount equal to that of the Company’s paid-in capital, and the remaining balance shall be listed or reverse special reserve pursuant to law. If the surplus is distributed in cash, the board of directors decides that the issuance of new shares shall be resolved by the shareholders’ meeting.

Article 22 The board of directors is authorized to deal with the Company’s external investment that exceeds 40% of the Company’s paid-in capital.

Chapter 7 Supplemental Provisions
40


Article 23 The matters that are not covered in the Articles of Incorporation shall be subject to the provisions of the Company Act and other relevant laws and regulations.

Article 24 The Articles of Incorporation was enacted on January 24, 1994.

1st amendment on November 19, 1996.
2nd amendment on June 16, 1998.
3rd amendment on August 31, 1999.
4th amendment on December 15, 1999.
5th amendment on December 22, 2000.
6th amendment on September 24, 2001.
7th amendment on May 15, 2002.
8th amendment on February 19, 2003.
9th amendment on July 8, 2003.
10th amendment on February 16, 2004.
11th amendment on August 7, 2006.
12th amendment on September 30, 2009.
13th amendment on December 7, 2009.
14th amendment on October 2, 2013.
15th amendment on June 23, 2014.
16th amendment on June 30, 2015.
17th amendment on February 15, 2016.
18th amendment on December 2, 2016.
19th amendment on June 20, 2018.
20th amendment on June 26, 2019.
21st amendment on June 22, 2022.
22nd amendment on June 28, 2023.
23rd amendment on June 25, 2025.

41


{Annex 2}

Double Bond Chemical Ind. Co., Ltd.
Rules and Procedures for Shareholders Meetings

Article 1 Purpose:

To establish a strong governance system and sound supervisory capabilities for the Company’s shareholders meetings, and to strengthen management capabilities, these Rules are adopted pursuant to Article 5 of the Corporate Governance Best Practice Principles for TWSE/GTSM Listed Companies.

Article 2 Scope of Application:

The rules of procedures for the Company’s shareholders meetings, except as otherwise provided by law, regulation, or the article of incorporation, shall be as provided in these Rules.

Article 3 Convening shareholders meetings and shareholders meeting notices:

  1. Unless otherwise provided by law or regulation, the Company’s shareholders meetings shall be convened by the board of directors.

  2. When the company holds a video conference for the shareholders’ meeting, unless otherwise stipulated by the Rules for Handling Stock Affairs of Publicly Issued Stock Companies, it should be specified in the articles of association and resolved by the board of directors. The video conference of the shareholders’ meeting should be resolved by the board of directors with the attendance of more than two-thirds of the directors and the consent of more than half of the attending directors.

  3. Changes to how the Company convenes its shareholders meeting shall be resolved by the board of directors and shall be made no later than mailing of the shareholders meeting notice.

  4. The Company shall prepare electronic versions of the shareholders meeting notice and proxy forms, and the origins of and explanatory materials relating to all proposals, including proposals for ratification, matters for deliberation, or the election or dismissal of directors or supervisors, and upload them to the Market Observation Post System (MOPS) 30 days before the date of a regular shareholders meeting or 15 days before the date of a special shareholders meeting. The Company shall prepare electronic versions of the shareholders meeting agenda and supplemental meeting materials and upload them to the MOPS 21 days before the date of the regular shareholders meeting or 15 days before the date of the special shareholders meeting. If, however, the Company has the paid-in capital of NT$10 billion or more as of the last day of the most current fiscal year, or total shareholding of foreign shareholders and PRC shareholders reaches 30% or more as recorded in the register of shareholders of the shareholders meeting held in the immediately preceding year, transmission of these electronic files shall be made by 30 days before the regular

42


shareholders meeting. In addition, 15 days before the date of the shareholders' meeting, the Company shall also have prepared the shareholders meeting agenda and supplemental meeting materials and made them available for review by shareholders at any time. The meeting agenda and supplemental materials shall also be displayed at this Company and the professional shareholder services agent designated thereby.

The Company shall make the meeting agenda and supplemental meeting materials in the preceding paragraph available to shareholders for review in the following manner on the date of the shareholders meeting:

(1) For physical shareholders meetings, to be distributed on-site at the meeting.
(2) For hybrid shareholders meetings, to be distributed on-site at the meeting and shared on the virtual meeting platform.
(3) For virtual-only shareholders meetings, electronic files shall be shared on the virtual meeting platform.

  1. The reasons for convening a shareholders meeting shall be specified in the meeting notice and public announcement. With the consent of the addressee, the meeting notice may be given in electronic form.

  2. Election or dismissal of directors or supervisors, amendments to the article of incorporation, the dissolution, merger, or demerger of the Company, or any matter under Article 185, paragraph 1 of the Company Act, Article 26-1 and 43-6 of the Securities and Exchange Act, or Articles 56-1 and 60-2 of the Regulations Governing the Offering and Issuance of Securities by Securities Issuers shall be set out in the notice of the reasons for convening the shareholders meeting. None of the above matters may be raised by extraordinary motion.

  3. The reason for convening the shareholders' meeting has stated the full re-election of directors and the date of appointment. After the re-election of the shareholders' meeting is completed, the date of appointment may not be changed by extraordinary motions or other means at the same meeting.

  4. A shareholder holding 1 percent or more of the total number of issued shares may submit to the Company a proposal for discussion at a regular shareholders meeting. Such proposals, however, are limited to one item only, and no proposal containing more than one item will be included in the meeting agenda. In addition, when the circumstances of any subparagraph of Article 172-1, paragraph 4 of the Company Act apply to a proposal put forward by a shareholder, the board of directors may exclude it from the agenda. Shareholders may submit proposals to urge the Company to promote public interest or fulfill its social responsibilities. Such proposals, in accordance with the relevant provisions of Article 172-1 of the Company Law, are limited to one item only, and no proposal containing more than one item will be included in the meeting agenda.

  5. Prior to the book closure date before a regular shareholders meeting is held, the Company shall

43


publicly announce that it will receive shareholder proposals, the method of receiving written or electronic proposals, and the location and time for their submission; the period for submission of shareholder proposals may not be less than 10 days.

  1. Shareholder-submitted proposals are limited to 300 words, and no proposal containing more than 300 words will be included in the meeting agenda. The shareholder making the proposal shall be present in person or by proxy at the regular shareholders meeting and take part in discussion of the proposal.

  2. Prior to the date for issuance of notice of a shareholders meeting, the Company shall inform the shareholders who submitted proposals of the proposal screening results and shall list in the meeting notice the proposals that conform to the provisions of this article. At the shareholders meeting the board of directors shall explain the reasons for exclusion of any shareholder proposals not included in the agenda.

Article 4 Proxy and authorization:

  1. For each shareholders meeting, a shareholder may appoint a proxy to attend the meeting by providing the proxy form issued by the Company and stating the scope of the proxy’s authorization.
  2. A shareholder may issue only one proxy form and appoint only one proxy for any given shareholders meeting and shall deliver the proxy form to the Company 5 days before the date of the shareholders meeting. When duplicate proxy forms are delivered, the one received earliest shall prevail unless a declaration is made to cancel the previous proxy appointment.
  3. After a proxy form has been delivered to the Company, if the shareholder intends to attend the meeting in person or to exercise voting rights by correspondence or electronically, a written notice of proxy cancellation shall be submitted to the Company 2 business days before the meeting date. If the cancellation notice is submitted after that time, votes cast at the meeting by the proxy shall prevail.

  4. If, after a proxy form is delivered to the Company, a shareholder wishes to attend the shareholders’ meeting online, a written notice of proxy cancellation shall be submitted to the Company, two business days before the meeting date. If the cancellation notice is submitted after that time, votes cast at the meeting by the proxy shall prevail.

Article 5 Principles determining the time and place of a shareholders meeting:

The venue for a shareholders meeting shall be the premises of the Company, or a place easily accessible to shareholders and suitable for a shareholders meeting. The meeting may begin no earlier than 9 a.m. and no later than 3 p.m. Full consideration shall be given to the opinions of the independent directors with respect to the place and time of the meeting. The restrictions on the place of the meeting shall not apply when the Company convenes a virtual-only shareholders’ meeting.

Article 6 Preparation of documents such as the attendance book:

44


  1. The Company shall specify in its shareholders meeting notices the time during which attendance registrations for shareholders, solicitors and proxies (collectively "shareholders") will be accepted, the place to register for attendance, and other matters for attention.

  2. The time during which shareholder attendance registrations will be accepted, as stated in the preceding paragraph, shall be at least 30 minutes prior to the time the meeting commences. The place at which attendance registrations are accepted shall be clearly marked and there will be enough suitable personnel assigned to handle the registrations. For virtual shareholders meetings, shareholders may begin to register on the virtual meeting platform 30 minutes before the meeting starts. Shareholders completing registration will be deemed to attend the shareholders meeting in person.

  3. Shareholders shall attend shareholders' meetings based on attendance cards, sign-in cards, or other certificates of attendance. The Company may not arbitrarily add requirements for other documents beyond those showing eligibility to attend presented by shareholders. Solicitors soliciting proxy forms shall also bring identification documents for verification.

  4. The Company shall furnish the attending shareholders with an attendance book to sign, or attending shareholders may hand in a sign-in card in lieu of signing in. The Company shall furnish attending shareholders with the meeting agenda book, annual report, attendance card, speaker's slips, voting slips, and other meeting materials. Where there is an election of directors or supervisors, pre-printed ballots shall also be furnished.

  5. When the government or a juristic person is a shareholder, it may be represented by more than one representative at a shareholders meeting. When a juristic person is appointed to attend as proxy, it may designate only one person to represent it in the meeting.

  6. In the event of a virtual shareholders meeting, shareholders wishing to attend the meeting online shall register with the Company two days before the meeting date. The Company shall upload the meeting agenda book, annual report and other meeting materials to the virtual meeting platform at least 30 minutes before the meeting starts, and keep this information disclosed until the end of the meeting.

Article 6-1 Convening virtual shareholders meetings and particulars to be included in shareholders meeting notice:

To convene a virtual shareholders meeting, the Company shall include the following particulars in the shareholders meeting notice:

  1. How shareholders attend the virtual meeting and exercise their rights.

  2. Actions to be taken if the virtual meeting platform or participation in the virtual meeting is obstructed due to natural disasters, accidents or other force majeure events, at least covering the following particulars:

45


A. To what time the meeting is postponed or from what time the meeting will resume if the above obstruction continues and cannot be removed, and the date to which the meeting is postponed or on which the meeting will resume.

B. Shareholders not having registered to attend the affected virtual shareholders meeting shall not attend the postponed or resumed session.

C. In case of a hybrid shareholders meeting, when the virtual meeting cannot be continued, if the total number of shares represented at the meeting, after deducting those represented by shareholders attending the virtual shareholders meeting online, meets the minimum legal requirement for a shareholder meeting, then the shareholders meeting shall continue. The shares represented by shareholders attending the virtual meeting online shall be counted towards the total number of shares represented by shareholders present at the meeting, and the shareholders attending the virtual meeting online shall be deemed abstaining from voting on all proposals on meeting agenda of that shareholders meeting.

D. Actions to be taken if the outcome of all proposals have been announced and extraordinary motion has not been carried out.

  1. To convene a virtual-only shareholders meeting, appropriate alternative measures available to shareholders with difficulties in attending a virtual shareholder meeting online shall be specified. Except for the circumstances stipulated in the sixth paragraph of Article 44-9 of the Rules for Handling Stock Affairs of Publicly Issued Stock Companies, at least connection equipment and necessary assistance should be provided to shareholders. It should also specify the period during which shareholders can apply to the company and other relevant matters that should be noted.

Article 7 The chair and non-voting participants of a shareholders meeting:

  1. If a shareholders meeting is convened by the board of directors, the meeting shall be chaired by the chairperson of the board. When the chairperson of the board is on leave or for any reason unable to exercise the powers of the chairperson, the vice chairperson shall act in place of the chairperson; if there is no vice chairperson or the vice chairperson also is on leave or for any reason unable to exercise the powers of the vice chairperson, the chairperson shall appoint one of the managing directors to act as chair, or, if there are no managing directors, one of the directors shall be appointed to act as chair. Where the chairperson does not make such a designation, the managing directors or the directors shall select from among themselves one person to serve as chair.

  2. When a managing director or a director serves as chair, as referred to in the preceding paragraph, the managing director or director shall be one who has held that position for six months or more and who understands the financial and business conditions of the Company. The same shall be true for a representative of a juristic director that serves as chair.

46


  1. It is advisable that shareholders meetings convened by the board of directors be chaired by the chairperson of the board in person and attended by most of the directors and at least one member of each functional committee on behalf of the committee. The attendance shall be recorded in the meeting minutes.

  2. If a shareholders meeting is convened by a party with power to convene but other than the board of directors, the convening party shall chair the meeting. When there are two or more such convening parties, they shall mutually select a chair from among themselves.

  3. The Company may appoint its attorneys, certified public accountants, or related people retained by it to attend a shareholders meeting in a non-voting capacity.

Article 8 Documentation of a shareholders meeting by audio or video:

  1. This Company, beginning from the time it accepts shareholder attendance registrations, shall make an uninterrupted audio and video recording of the registration procedure, the proceedings of the shareholders meeting, and the voting and vote counting procedures.

  2. The recorded materials of the preceding paragraph shall be retained for at least 1 year. If, however, a shareholder files a lawsuit pursuant to Article 189 of the Company Act, the recording shall be retained until the conclusion of the litigation.

  3. Where a shareholders meeting is held online, this Corporation shall keep records of shareholder registration, sign-in, check-in, questions raised, votes cast and results of votes counted by this Corporation, and continuously audio and video record, without interruption, the proceedings of the virtual meeting from beginning to end.

  4. The information and audio and video recording in the preceding paragraph shall be properly kept by this Corporation during the entirety of its existence, and copies of the audio and video recording shall be provided to and kept by the party appointed to handle matters of the virtual meeting.

  5. In case of a virtual shareholders meeting, this Corporation is advised to audio and video record the back-end operation interface of the virtual meeting platform.

Article 9 Attendance at shareholders meetings calculated based on number of shares:

  1. Attendance at shareholders meetings shall be calculated based on numbers of shares. The number of shares in attendance shall be calculated according to the shares indicated by the attendance book and sign-in cards handed in, and the shares checked in on the virtual meeting platform, plus the number of shares whose voting rights are exercised by correspondence or electronically.

  2. The chair shall call the meeting to order at the appointed meeting time. At the same time, the number of non-voting rights and the number of shares present shall be announced. However, when the attending shareholders do not represent most of the total number of issued shares, the chair may announce a postponement, provided that no more than two such postponements, for a combined total of no more than 1 hour, may be made. If the quorum is not met after two

47


postponements and the attending shareholders still represent less than one third of the total number of issued shares, the chair shall declare the meeting adjourned. In the event of a virtual shareholders meeting, the Company shall also declare the meeting adjourned at the virtual meeting platform.

  1. If the quorum is not met after two postponements as referred to in the preceding paragraph, but the attending shareholders represent one third or more of the total number of issued shares, a tentative resolution may be adopted pursuant to Article 175, paragraph 1 of the Company Act; all shareholders shall be notified of the tentative resolution and another shareholders meeting shall be convened within 1 month. In the event of a virtual shareholders meeting, shareholders intending to attend the meeting online shall re-register to the Company in accordance with Article 6.

  2. When, prior to conclusion of the meeting, the attending shareholders represent most of the total number of issued shares, the chair may resubmit the tentative resolution for a vote by the shareholders meeting pursuant to Article 174 of the Company Act.

Article 10 Discussion of proposal:

  1. If a shareholders meeting is convened by the board of directors, the meeting agenda shall be set by the board of directors. Votes shall be cast on each separate proposal in the agenda (including extraordinary motions and amendments to the original proposals set out in the agenda). The meeting shall proceed in the order set by the agenda, which may not be changed without a resolution of the shareholders meeting.

  2. The provisions of the preceding paragraph apply mutatis mutandis to a shareholders meeting convened by a party with the power to convene that is not the board of directors.

  3. The chair may not declare the meeting adjourned prior to completion of deliberation on the meeting agenda of the preceding two paragraphs (including extraordinary motions), except by a resolution of the shareholders meeting. If the chair declares the meeting adjourned in violation of the rules of procedure, the other members of the board of directors shall promptly assist the attending shareholders in electing a new chair in accordance with statutory procedures, by agreement of a majority of the votes represented by the attending shareholders and then continue the meeting.

  4. The chair shall allow ample opportunity during the meeting for explanation and discussion of proposals and of amendments or extraordinary motions put forward by the shareholders; when the chair is of the opinion that a proposal has been discussed sufficiently to put it to a vote, the chair may announce the discussion closed and call for a vote, and provide adequate voting time.

Article 11 Shareholder speech:

  1. Before speaking, an attending shareholder must specify on a speaker’s slip the subject of the speech, his/her shareholder account number (or attendance card number), and account name. The

48


order in which shareholders speak will be set by the chair.

  1. A shareholder in attendance who has submitted a speaker’s slip but does not actually speak shall be deemed to have not spoken. When the content of the speech does not correspond to the subject given on the speaker’s slip, the spoken content shall prevail.

  2. Except with the consent of the chair, a shareholder may not speak more than twice on the same proposal, and a single speech may not exceed 5 minutes. If the shareholder’s speech violates the rules or exceeds the scope of the agenda item, the chair may terminate the speech.

  3. When an attending shareholder is speaking, other shareholders may not speak or interrupt unless they have sought and obtained the consent of the chair and the shareholder that has the floor; the chair shall stop any violation.

  4. When a juristic person shareholder appoints two or more representatives to attend a shareholders meeting, only one of the representatives appointed may speak on the same proposal.

  5. After an attending shareholder has spoken, the chair may respond in person or direct relevant personnel to respond.

  6. Where a virtual shareholders meeting is convened, shareholders attending the virtual meeting online may raise questions in writing at the virtual meeting platform from the chair declaring the meeting open until the chair declaring the meeting adjourned. No more than two questions for the same proposal may be raised. Each question shall contain no more than 200 words. The regulations in paragraphs 1 to 5 do not apply. If questions so raised in accordance with the preceding paragraph are not in violation of the regulations or beyond the scope of a proposal, it is advisable the questions be disclosed to the public at the virtual meeting platform.

Article 12 Calculation of voting shares and recusal system:

  1. Voting at a shareholders meeting shall be calculated based on the number of shares.

  2. With respect to resolutions of shareholders meetings, the number of shares held by a shareholder with no voting rights shall not be calculated as part of the total number of shares issued.

  3. When a shareholder is an interested party in relation to an agenda item, and there is the likelihood that such a relationship would prejudice the interests of the Company, that shareholder may not vote on that item, and may not exercise voting rights as proxy for any other shareholder.

  4. The number of shares for which voting rights may not be exercised under the preceding paragraph shall not be calculated as part of the voting rights represented by attending shareholders.

  5. Except for a trust enterprise or a shareholder services agent approved by the competent securities authority, when one person is concurrently appointed as proxy by two or more shareholders, the voting rights represented by that proxy may not exceed 3 percent of the voting rights represented by the total number of issued shares. If that percentage is exceeded, the voting rights more than that percentage shall not be included in the calculation.

49


Article 13 Votes:

  1. A shareholder shall be entitled to one vote for each share held, except when the shares are restricted to shares under Article 179, paragraph 2 of the Company Act.

  2. When the Company holds a shareholders meeting, it may allow the shareholders to exercise voting rights by correspondence or electronic means. When voting rights are exercised by correspondence or electronic means, the method of exercise shall be specified in the shareholders meeting notice. A shareholder exercising voting rights by correspondence or electronic means will be deemed to have attended the meeting in person, but to have waived his/her rights with respect to the extraordinary motions and amendments to original proposals of that meeting; it is therefore advisable that the Company avoid the submission of extraordinary motions and amendments to original proposals.

  3. A shareholder intending to exercise voting rights by correspondence or electronic means under the preceding paragraph shall deliver a written declaration of intent to the Company 2 days before the date of the shareholders meeting. When duplicate declarations of intent are delivered, the one received earliest shall prevail, except when a declaration is made to cancel the earlier declaration of intent.

  4. After a shareholder has exercised voting rights by correspondence or electronic means, in the event the shareholder intends to attend the shareholders meeting in person or online, a written declaration of intent to retract the voting rights already exercised under the preceding paragraph shall be made known to the Company, by the same means by which the voting rights were exercised, 2 business days before the date of the shareholders meeting. If the notice of retraction is submitted after that time, the voting rights already exercised by correspondence or electronic means shall prevail. When a shareholder has exercised voting rights both by correspondence or electronic means and by appointing a proxy to attend a shareholders meeting, the voting rights exercised by the proxy in the meeting shall prevail.

  5. Except as otherwise provided in the Company Act and in this Company’s articles of incorporation, the passage of a proposal shall require an affirmative vote of most of the voting rights represented by the attending shareholders. At the time of a vote, for each proposal, the chair or a person designated by the chair shall first announce the total number of voting rights represented by the attending shareholders, followed by a poll of the shareholders. After the conclusion of the meeting, on the same day it is held, the results for each proposal, based on the numbers of votes for and against and the number of abstentions, shall be entered into the MOPS.

  6. When there is an amendment or an alternative to a proposal, the chair shall present the amended or alternative proposal together with the original proposal and decide the order in which they

50


will be put to vote. When any one among them is passed, the Other Matters will then be deemed rejected, and no further voting shall be required.

  1. Vote monitoring and counting personnel for the voting on a proposal shall be arranged by the chair, provided that all monitoring personnel shall be shareholders of the Company.

  2. Vote counting for shareholders meeting proposals or elections shall be conducted in public at the place of the shareholders meeting. Immediately after vote counting has been completed, the results of the voting, including the statistical tallies of the numbers of votes, shall be announced on-site at the meeting, and a record made of the vote.

  3. When the Company convenes a virtual shareholders meeting, after the chair declares the meeting open, shareholders attending the meeting online shall cast votes on proposals and elections on the virtual meeting platform before the chair announces the voting session ends or will be deemed abstained from voting.

  4. In the event of a virtual shareholders meeting, votes shall be counted at once after the chair announces the voting session ends, and results of votes and elections shall be announced immediately.

  5. When the Company convenes a hybrid shareholders meeting, if shareholders who have registered to attend the meeting online in accordance with Article 6 decide to attend the physical shareholders meeting in person, they shall revoke their registration two days before the shareholders meeting in the same manner as they registered. If their registration is not revoked within the time limit, they may only attend the shareholders meeting online.

  6. When shareholders exercise voting rights by correspondence or electronic means, unless they have withdrawn the declaration of intent and attended the shareholders meeting online, except for extraordinary motions, they will not exercise voting rights on the original proposals or make any amendments to the original proposals or exercise voting rights on amendments to the original proposal.

Article 14 Election of directors and supervisors:

  1. The election of directors or supervisors at a shareholders meeting shall be held in accordance with the applicable election and appointment rules adopted by the Company, and the voting results shall be announced on-site immediately, including the names of those elected as directors and supervisors, the numbers of votes with which they were elected, the names of those failed-elected as directors and the numbers of votes with which they were obtained.

  2. The ballots for the election referred to in the preceding paragraph shall be sealed with the signatures of the monitoring personnel and kept in proper custody for at least 1 year. If, however, a shareholder files a lawsuit pursuant to Article 189 of the Company Act, the ballots shall be retained until the conclusion of the litigation.

51


Article 15 Meeting minutes and signatures:

  1. Matters relating to the resolutions of a shareholders meeting shall be recorded in the meeting minutes. The meeting minutes shall be signed or sealed by the chair of the meeting and a copy distributed to each shareholder within 20 days after the conclusion of the meeting. The meeting minutes may be produced and distributed in electronic form.

  2. The Company may distribute the meeting minutes of the preceding paragraph by means of a public announcement made through MOPS.

  3. The meeting minutes shall accurately record the year, month, day, and place of the meeting, the chair’s full name, the methods by which resolutions were adopted, and a summary of the deliberations and their results (Including statistical weights). When electing directors, the number of votes for each candidate should be written. The meeting minutes shall be retained for the duration of the existence of the Company.

  4. Where a virtual shareholders meeting is convened, in addition to the particulars to be included in the meeting minutes as described in the preceding paragraph, the start time and end time of the shareholders meeting, how the meeting is convened, the chair's and secretary's name, and actions to be taken in the event of disruption to the virtual meeting platform or participation in the meeting online due to natural disasters, accidents or other force majeure events, and how issues are dealt with shall also be included in the minutes.

  5. When convening a virtual-only shareholder meeting, other than compliance with the requirements in the preceding paragraph, the Company shall specify in the meeting minutes alternative measures available to shareholders with difficulties in attending a virtual-only shareholders meeting online.

Article 16 Public disclosure:

  1. On the day of a shareholders meeting, the Company shall compile in the prescribed format a statistical statement of the number of shares obtained by solicitors through solicitation and the number of shares represented by proxies and the number of shares represented by shareholders attending the meeting by correspondence or electronic means, and shall make an express disclosure of the same at the place of the shareholders meeting. In the event of a virtual shareholders meeting, the Company shall upload the above meeting materials to the virtual meeting platform at least 30 minutes before the meeting starts, and keep this information disclosed until the end of the meeting.

  2. During the Company’s virtual shareholders meeting, when the meeting is called to order, the total number of shares represented at the meeting shall be disclosed on the virtual meeting platform. The same shall apply whenever the total number of shares represented at the meeting and a new tally of votes is released during the meeting.

52


  1. If matters put to a resolution at a shareholders meeting constitute material information under applicable laws or regulations or under Taiwan Stock Exchange Corporation (or GreTai Securities Market) regulations, the Company shall upload the content of such resolution to the MOPS within the prescribed time.

Article 17 Maintaining order at the meeting place:

  1. Staff handling administrative affairs of a shareholders meeting shall wear identification cards or armbands.
  2. The chair may direct the proctors or security personnel to help maintain order at the meeting place. When proctors or security personnel help maintain order at the meeting place, they shall wear an identification card or armband bearing the word "Proctor".
  3. At the place of a shareholders meeting, if a shareholder attempts to speak through any device other than the public address equipment set up by the Company, the chair may prevent the shareholder from so doing.
  4. When a shareholder violates the rules of procedure and defies the chair's correction, obstructing the proceedings and refusing to heed calls to stop, the chair may direct the protectors or security personnel to escort the shareholder from the meeting.

Article 18 Recess and resumption of a shareholders meeting:

  1. When a meeting is in progress, the chair may announce a break based on time considerations. If a natural disaster takes place, the chair may rule the meeting suspended and announce a time when, in view of the circumstances, the meeting will be resumed.
  2. If the meeting venue is no longer available for continued use and not all the items (including extraordinary motions) on the meeting agenda have been addressed, the shareholders meeting may adopt a resolution to resume the meeting at another venue.
  3. A resolution may be adopted at a shareholder meeting to defer or resume the meeting within 5 days in accordance with Article 182 of the Company Act.

Article 19 Disclosure of information at virtual meetings

In the event of a virtual shareholders meeting, the Company shall disclose real -time results of votes and election immediately after the end of the voting session on the virtual meeting platform according to the regulations, and this disclosure shall continue at least 15 minutes after the chair has announced the meeting adjourned.

Article 20 Location of the chair and secretary of virtual-only shareholders meeting

When the Company convenes a virtual -only shareholders meeting, both the chair and secretary shall be in the same location, and the chair shall declare the address of their location when the meeting is called to order.

Article 21 Handling of disconnection

53


  1. In the event of a virtual shareholders meeting, the Company may offer a simple connection test to shareholders prior to the meeting and provide relevant real-time services before and during the meeting to help resolve communication technical issues.

  2. In the event of a virtual shareholders meeting, when declaring the meeting open, the chair shall also declare, unless under a circumstance where a meeting is not required to be postponed to or resumed at another time under Article 44-20, paragraph 4 of the Regulations Governing the Administration of Shareholder Services of Public Companies, if the virtual meeting platform or participation in the virtual meeting is obstructed due to natural disasters, accidents or other force majeure events before the chair has announced the meeting adjourned, and the obstruction continues for more than 30 minutes, the meeting shall be postponed to or resumed on another date within five days, in which case Article 182 of the Company Act shall not apply.

  3. For a meeting to be postponed or resumed as described in the preceding paragraph, shareholders who have not registered to participate in the affected shareholders meeting online shall not attend the postponed or resumed session.

  4. For a meeting to be postponed or resumed under the second paragraph, the number of shares represented by, and voting rights and election rights exercised by the shareholders who have registered to participate in the affected shareholders meeting and have successfully signed in the meeting, but do not attend the postpone or resumed session, at the affected shareholders meeting, shall be counted towards the total number of shares, number of voting rights and number of election rights represented at the postponed or resumed session.

  5. During a postponed or resumed session of a shareholders meeting held under the second paragraph, no further discussion or resolution is required for proposals for which votes have been cast and counted and results have been announced, or list of elected directors and supervisors.

  6. When the Company convenes a hybrid shareholders meeting, and the virtual meeting cannot continue as described in second paragraph, if the total number of shares represented at the meeting, after deducting those represented by shareholders attending the virtual shareholders meeting online, still meets the minimum legal requirement for a shareholder meeting, then the shareholders meeting shall continue, and not postponement or resumption thereof under the second paragraph is required.

  7. Under the circumstances where a meeting should continue as in the preceding paragraph, the shares represented by shareholders attending the virtual meeting online shall be counted towards the total number of shareholders present at the meeting, provided these shareholders shall be deemed abstaining from voting on all proposals on meeting agenda of that shareholders meeting.

  8. When postponing or resuming a meeting according to the second paragraph, the Company shall handle the preparatory work based on the date of the original shareholders meeting in accordance

54


with the requirements listed under Article 44-20, paragraph 7 of the Regulations Governing the Administration of Shareholder Services of Public Companies.

  1. For dates or period set forth under Article 12, second half, and Article 13, paragraph 3 of Regulations Governing the Use of Proxies for Attendance at Shareholder Meetings of Public Companies, and Article 44-5, paragraph 2, Article 44-15, and Article 44-17, paragraph 1 of the Regulations Governing the Administration of Shareholder Services of Public Companies, the Company shall handle the matter based on the date of the shareholders meeting that is postponed or resumed under the second paragraph.

Article 22 Handling of digital divide

When convening a virtual-only shareholders meeting, the Company shall provide appropriate alternative measures available to shareholders with difficulties in attending a virtual shareholder meeting online. Except for the circumstances stipulated in the sixth paragraph of Article 44-9 of the Rules for Handling Stock Affairs of Publicly Issued Stock Companies, at least connection equipment and necessary assistance should be provided to shareholders. It should also specify the period during which shareholders can apply to the company and other relevant matters that should be noted.

Article 23 Validation and amendment:

These Rules, and any amendments hereto, shall be implemented after adoption by shareholders’ meetings.

55


{Annex 3}

Double Bond Chemical Ind. Co., Ltd.
The Procedures for Election of Directors

Article 1 Purpose of formulation:

To elect directors justly, fairly and openly, the procedures are formulated in accordance with Articles 21 and 41 of the Code of Practice for Governance of Listed and OTC Companies for compliance.

Article 2 Scope of application:

The selection of directors of the Company shall be conducted in accordance with the procedures, unless otherwise stipulated in laws or articles of incorporation.

Article 3 Directors shall possess the following abilities:

  1. The selection of directors of the Company shall consider the overall arrangement of the Board of Directors. The composition of the Board of Directors shall consider diversification and formulate appropriate diversification policies on its own operation, operation type and development needs, which should include but not be limited to the following two major standards:

A. Basic conditions and values: gender, age, nationality and culture, etc.

B. Professional knowledge and skills: professional background (such as law, accounting, industry, finance, marketing or science and technology), professional skills and industrial experience, etc.

  1. The members of the Board of Directors generally have the necessary knowledge, skills and accomplishments to perform their duties, and their overall abilities shall be as follows:

A. Operational judgment.
B. Ability of accounting and financial analysis.
C. Management capability.
D. Crisis handling capacity.
E. Industrial knowledge.
F. International market outlook.
G. Leadership.
H. Decision-making ability.

  1. Directors shall have more than half of the seats and shall not have spouse or kinship within the second degree.

  2. The Board of Directors of the Company shall consider and adjust the composition of the Board according to the results of performance evaluation

56


Article 4 Conditions for the selection of independent directors:

  1. The qualifications of independent directors of the Company shall comply with Articles 2, 3 and 4 of the Measures for the Establishment and Compliance of Independent Directors of Public Offering Companies.

  2. The selection of independent directors of the Company shall comply with the provisions of Articles 5, 6, 7, 8 and 9 of the Measures for the Establishment and Compliance of Independent Directors of Public Offering Companies and shall be handled in accordance with the provisions of Article 24 of the Code of Practice for the Governance of Listed and OTC Companies.

Article 5 Election method of directors:

  1. The election of directors of the Company shall be conducted in accordance with the candidate nomination system and procedures set out in Article 192-1 of the Company Act.

  2. The election of directors of the Company shall adopt a cumulative voting system. Each share shall have the same voting right as the number of directors to be elected. One person may be elected collectively, or several people may be elected.

Article 6 Method of vacancy by-election of directors:

  1. If the number of directors is less than five because of dismissal for some reason, the Company shall hold a byelection at the latest shareholders' meeting. However, if the vacancy of directors reaches one-third of the seats stipulated in the Articles of Incorporation, the Company shall convene an interim meeting of shareholders to elect the directors within 60 days of the date of occurrence of the facts.

  2. If the number of independent directors is less than the provision of Paragraph 1 of Article 14, bis of the Securities and Exchange Act, shall be by-elected at the latest shareholders' meeting. When all independent directors are dismissed, an interim shareholders' meeting shall be held for election within 60 days from the date of occurrence of the facts.

Article 7 Preparation of ballot tickets:

The Board of Directors shall prepare an ballot ticket with the same number of directors to be elected, fill in its weight, and distribute it to the shareholders attending the shareholders' meeting. The registered name of the elector may be replaced by the attendance card number printed on the ballot ticket.

Article 8 Number of directors and the method of election:

The directors of the Company shall calculate the voting rights of independent directors and non-independent directors respectively according to the quota set in the Articles of

57


Incorporation of the Company. Those with more voting rights shall be elected one after the other. If more than two persons have the same weight and exceed the quota, the voting rights of those with the same weight shall be determined by drawing lots, and those who do not attend shall be drawn lots by the chairman.

Article 9 Supervision and counting of tickets:

Before the election begins, the chairman shall designate several scrutineers and tellers to perform various related duties, but the scrutineer shall have the status of shareholders. Ballot boxes are prepared by the Board of Directors and checked by the scrutineers in public before voting.

Article 10 Ballot tickets are invalid in one of the following events:

  1. Those who do not use ballot tickets prepared by the Convener.
  2. Put blank ballot tickets into ballot boxes.
  3. Illegible or altered handwriting.
  4. The electee does not match with List of Director Candidates after verification.
  5. In addition to the number of voting rights allocated, those which wrote other words.

Article 11 Opening ballot box and preservation of ballot tickets:

  1. The box will be opened on the spot after the vote is completed. The results shall be announced on the spot by the chairman or designated personnel for the election list and the election weight.
  2. The ballot tickets aforesaid shall be sealed and signed by the scrutineer and shall be kept properly for at least one year. However, if a shareholder files a lawsuit in accordance with Article 189 of the Company Act, the ballot tickets aforesaid shall be kept until the end of the lawsuit.

Article 12 Notification of election:

The Board of Directors of the Company shall issue a notice of election to the elected directors.

Article 13 Entry into force and amendments:

The Rules shall come into force upon approval by the shareholders' meeting, and the same shall apply to amendments.

58


【Annex 4】

Double Bond Chemical Ind. Co., Ltd.

Shareholding of All Directors

  1. The Company’s paid-in capital is NT$855,420,620; total number of shares issued are 85,542,062 shares.

  2. According to Article 2 of “Rules and Review Procedures for Director and Supervisor Share Ownership Ratios at Public Companies”, The shareholdings of independent directors elected by a public company shall not be counted in the total referred to in the preceding paragraph; if a public company has elected two or more independent directors, the share ownership figures calculated at the rates set forth in the preceding paragraph for all directors and supervisors other than the independent directors and shall be decreased by 20 percent. If a public company has set up an audit committee in accordance with the Act, the provisions on the minimum percentage requirements for the shareholding of supervisors in the preceding two paragraphs shall not apply.

  3. The minimum number of shares held by all directors of the company is as follows: Shares held by all directors legally (8%): 6,843,364 shares.

  4. As of the suspended transferring date of this shareholders’ meeting (April 27, 2026), each and all directors’ shareholding status recorded in the shareholders’ list are listed in the schedule below:

Title Name Shareholding condition as of April 27, 2026
Chairman TSAY, MAW-DER 2,959,372
Director LIN, LIANG 1,184,683
Director LEE, KUN-CHANG 6,757,320
Director Representative of Jatdix Investments International Limited LIU, CHIEN-LIANG 8,493,770
Independent Director TSAI, KAO-CHUNG 0
Independent Director LEE, SHUEI-SHENG 132,220
Total number of shares held by all directors 19,527,365

60

【Annex 5】

Other Matters

The acceptance of the shareholders’ proposal of this regular shareholders’ meeting is as follows:

  1. According to Article 172-1 of the Company Act, “Shareholder(s) holding one percent (1%) or more of the total number of outstanding shares of a company may propose to the company a proposal for discussion at a regular shareholders’ meeting, provided that only one matter shall be allowed in each single proposal, and in case a proposal contains more than one matter, such proposal shall not be included in the agenda. The number of words of a proposal to be submitted by a shareholder shall be limited to not more than three hundred (300) words, and any proposal containing more than 300 words shall not be included in the agenda of the shareholders’ meeting. The shareholder who has submitted a proposal shall attend, in person or by proxy, the regular shareholders’ meeting whereat his proposal is to be discussed and shall take part in the discussion of such proposal.

  2. The acceptance period of the shareholder proposal this time is from April 18, 2026 to April 28, 2026, and has already been announced on the Market Observation Post System (MOPS).

  3. The Company did not receive any shareholder proposal during the acceptance period of shareholder proposal.